Literature DB >> 2221862

Branched-chain fatty acids produced by mutants of Streptomyces fradiae, putative precursors of the lactone ring of tylosin.

M L Huber1, J W Paschal, J P Leeds, H A Kirst, J A Wind, F D Miller, J R Turner.   

Abstract

Three branched-chain fatty acids (7-hydroxy-4,6-dimethylnona-2,4-dienoic acid [compound 1], its 7-epimer [compound 2], and 7-keto-4,6-dimethylnona-2,4-dienoic acid [compound 3]) and a ketone (9-hydroxy-6,8-dimethylundeca-4,6-dien-3-one [compound 4]) were isolated from the culture broth of mutants of Streptomyces fradiae which were blocked in the biosynthesis of the macrolide antibiotic tylosin. Two phenotypic classes of mutants of this organism which were blocked in the addition of mycaminose to tylactone (compound 6) accumulated these compounds. These compounds were not produced by mutants which were blocked in lactone synthesis, in steps beyond mycaminose addition, or by the wild-type strain. Synthesis of these compounds, like synthesis of tylosin, was inhibited by the addition of cerulenin. Compounds 1, 2, and 3 were partially interconvertible by these mutants; but they were not produced from the degradation of tylactone and they were not directly incorporated into tylosin by intact cells. The structures of compounds 1 and 2 were equivalent to that of a predicted intermediate (S. Yue, J. S. Duncan, Y. Yamamoto, and C. R. Hutchinson, J. Am. Chem. Soc. 109:1253-1255, 1987) in the biosynthesis of tylactone. The ketone (compound 4) reported previously (N. D. Jones, M. O. Chaney, H. A. Kirst, G. M. Wild, R. H. Baltz, R. L. Hamill, and J. W. Paschal, J. Antibiot. 35:420-425, 1982) appears to be the decarboxylation product of the intermediate following that represented by compound 1. This represents the first report of the isolation of putative precursors of tylactone from tylosin-producing organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221862      PMCID: PMC171868          DOI: 10.1128/AAC.34.8.1535

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Carbon-13 nuclear magnetic resonance spectral analysis of 16-membered macrolide antibiotics.

Authors:  S Omura; A Nakagawa; A Neszmélyi; S D Gero; A M Sepulchre; F Piriou; G Lukacs
Journal:  J Am Chem Soc       Date:  1975-07-09       Impact factor: 15.419

2.  Actinomycete antibiotics. III. The biogenesis of erythronolide, the C-21 branched chain lactone in erythromycin.

Authors:  T KANEDA; J C BUTTE; S B TAUBMAN; J W CORCORAN
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

3.  The biosynthesis of picromycin using 13C enriched precursors.

Authors:  S Omura; H Takeshima; A Nakagawa; J Miyazawa
Journal:  J Antibiot (Tokyo)       Date:  1976-03       Impact factor: 2.649

4.  Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.

Authors:  S Omura; H Takeshima
Journal:  J Biochem       Date:  1974-01       Impact factor: 3.387

Review 5.  The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis.

Authors:  S Omura
Journal:  Bacteriol Rev       Date:  1976-09

6.  Biosynthesis of the macrolide antibiotic tylosin. A preferred pathway from tylactone to tylosin.

Authors:  R H Baltz; E T Seno; J Stonesifer; G M Wild
Journal:  J Antibiot (Tokyo)       Date:  1983-02       Impact factor: 2.649

7.  Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using enzyme inhibitor: cerulenin.

Authors:  S Omura; C Kitao; J Miyazawa; H Imai; H Takeshima
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649

8.  Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using enzyme inhibitor: cerulenin.

Authors:  S Omura; C Kitao; H Hamada; H Ikeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-01       Impact factor: 1.645

9.  Novel fermentation products from Streptomyces fradiae: X-ray crystal structure of 5-O-mycarosyltylactone and proof of the absolute configuration of tylosin.

Authors:  N D Jones; M O Chaney; H A Kirst; G M Wild; R H Baltz; R L Hamill; J W Paschal
Journal:  J Antibiot (Tokyo)       Date:  1982-04       Impact factor: 2.649

10.  The use of recombinant DNA techniques to study tylosin biosynthesis and resistance in Streptomyces fradiae.

Authors:  K L Cox; S E Fishman; J L Larson; R Stanzak; P A Reynolds; W K Yeh; R M van Frank; V A Birmingham; C L Hershberger; E T Seno
Journal:  J Nat Prod       Date:  1986 Nov-Dec       Impact factor: 4.050

View more
  2 in total

1.  Production of a polyhydroxyalkanoate biopolymer in insect cells with a modified eucaryotic fatty acid synthase.

Authors:  M D Williams; J A Rahn; D H Sherman
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

2.  Direct evidence that the rifamycin polyketide synthase assembles polyketide chains processively.

Authors:  T W Yu; Y Shen; Y Doi-Katayama; L Tang; C Park; B S Moore; C Richard Hutchinson; H G Floss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.